For patients on broader longevity or optimization protocols, GHK-Cu injections may also be combined with NAD+ therapy, BPC-157, or other peptides depending on their clinical goals
In this case, it is noteworthy that the GLP-1 agonist group had no worse visual outcomes compared to the acetazolamide monotherapy group across all primary outcome measures despite the increased risk due to their higher baseline BMI, the researchers wrote in their paper
Who Might Be a Good Candidate Daily oral semaglutide can be a suitable choice for people who: Prefer a tablet over injections Are managing type 2 diabetes and weight concurrently Want a medically supported GLP-1 strategy under doctor's supervision
And basically, cardiorespiratory fitness, which is a marker of health
GLP-1 receptor agonists are a class of medications commonly prescribed to people with type 2 diabetes
When youre thirsty, your body may perceive thirst signals as hunger signals